期刊文献+

线粒体功能障碍与脓毒血症发病机制及治疗的研究进展 被引量:8

Research progress of mitochondrial dysfunction in sepsis
在线阅读 下载PDF
导出
摘要 脓毒血症(sepsis)是指机体对感染的反应失调导致危及生命的多器官功能障碍。脓毒血症是重症监护患者死亡的主要原因,但其诱发多器官功能衰竭的机制至今仍未阐明。线粒体是细胞重要的细胞器,承担细胞内能量供应及信号调节等多种功能。线粒体功能障碍可能是脓毒血症导致多器官功能衰竭的重要原因之一。本文阐述了线粒体的病理生理功能及其在脓毒血症多器官功能衰竭中的可能损伤机制,并总结了脓毒血症中着眼于线粒体开展的治疗方案,为临床脓毒血症提供治疗靶点或新思路。 Sepsis is life-threatening multiple organ failure(MOF)caused by the disorder of body's response to infection.Although it is the main reason of death in intensive care patients,the mechanism of sepsis-induced MOF is still unclear.As an essential organelle of cells,mitochondrial is responsible for many funtions in cells such as energy supply and signal regulation.Recent researches showed that mitochondrial dysfunction may be one of the important reasons of MOF.This review describes the pathophysiological functions of mitochondria and the pathological damage mechanisms of MOF in sepsis,it will provide the therapeutic targets or new ideas for clinical treatment of sepsis.
作者 魏艳龙 董孝彧 尚志文 张共鹏 程志鹏 高琴 WEI Yanlong;DONG Xiaoyu;SHANG Zhiwen;ZHANG Gongpeng;CHENG Zhipeng;GAO Qin(Clinical Medical College,Bengbu Medical College,Bengbu 233000,Anhui,China;Department of Physiology,Bengbu Medical College,Bengbu 233000,Anhui,China)
出处 《中国临床药理学与治疗学》 CAS CSCD 2021年第11期1292-1299,共8页 Chinese Journal of Clinical Pharmacology and Therapeutics
基金 国家自然科学基金项目(81770297) 国家大学生创新创业项目(202010367014,202010367061)。
关键词 脓毒血症 线粒体功能障碍 多器官功能衰竭 sepsis mitochondrial dysfunction multiple organ failure
作者简介 魏艳龙,男,本科生,研究方向:心血管损伤与修复,Tel:19855081882,E-mail:985545236@qq.com;通信作者:高琴,女,博士,教授,硕士生导师,研究方向:心血管损伤与修复,Tel:18909659912,E-mail:bbmcgq@126.com。
  • 相关文献

参考文献3

二级参考文献26

  • 1Wenjie Wei,Richard Graeff,Jianbo Yue.Roles and mechanisms of the CD38/cyclic adenosine diphosphate ribose/Ca^(2+) signaling pathway[J].World Journal of Biological Chemistry,2014,5(1):58-67. 被引量:4
  • 2American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis [J]. Crit Care Med, 1992, 20(6) : 864-874.
  • 3Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ ACCP/ATS/SIS International Sepsis Definitions Conference [ J ]. Intensive Care Med, 2003, 29(4): 530-538.
  • 4Rhee C, Gohil S, Klompas M. Regulatory mandates for sepsis for caution [ J ]. N Engl J Med, 2014,370 ( 18 ) 1673-1676.
  • 5Schlapbach LJ, Straney L, Alexander J, et al. Mortality related to invasive infections, sepsis, and septic shock in critically ill children in Australia and New Zealand, 2002-13: a multicentre retrospective cohort study [ J]. Lancet Infect Dis, 2015,15 ( 1 ) :46-54.
  • 6Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock ( Sepsis-3 ) [ J ]. JAMA, 2016,315 ( 8 ) : 801-810.
  • 7Simpson SQ . New Sepsis Criteria : A Change We Should Not Make [ OL/J ] . Chest, 2016, [ 2016-03-02 ] . http:// www. ncbi. nlm. nih. gov/pubmed/26927525. [ published online ahead of print Feb 26,2016].
  • 8叶艺峰,胡淑辉,陈彦青,王庆祥.右美托咪定对脓毒症大鼠急性肾损伤的影响:与肾组织HMGB1 mRNA的关系[J].中华麻醉学杂志,2018,38(6):763-765. 被引量:5
  • 9李红霞,翁亦齐,喻文立.右美托咪定减轻成人肝移植受者术后心肌损伤的作用[J].中华器官移植杂志,2018,39(6):354-358. 被引量:4
  • 10江利冰,李瑞杰,张斌,刘孜卓,刘丽丽,陈梦飞,曾兰兰,蒋守银,姜生茂,张茂.2016年脓毒症与脓毒性休克处理国际指南[J].中华急诊医学杂志,2017,26(3):263-266. 被引量:163

共引文献15

同被引文献100

引证文献8

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部